Liminatus Pharma Inc. Reports Recent Stock Performance

Liminatus Pharma Inc., a company listed on the Nasdaq, has recently experienced notable fluctuations in its stock price. As of June 1, 2025, the close price of Liminatus Pharma Inc. was recorded at $5.39. This figure represents a significant movement from its 52-week low of $4.40, which was observed on May 27, 2025. The company’s stock reached a 52-week high of $16.44 on April 30, 2025, indicating a period of volatility within the year.

The market capitalization of Liminatus Pharma Inc. stands at approximately $135,796,363, reflecting its current valuation in the market. The company’s performance over the past year highlights the dynamic nature of the biopharmaceutical sector, where stock prices can be influenced by various factors including clinical trial results, regulatory approvals, and market sentiment.

Investors and stakeholders are closely monitoring Liminatus Pharma Inc. as it navigates the challenges and opportunities within the industry. The company’s strategic initiatives and future developments will be key in determining its trajectory in the coming months.